Serum ferritin level required for adequate response to recombinant human erythropoietin in haemodialysis patients with hepatitis C virus infection.
Hung
K Y
KY
Wu
D J
DJ
Wu
K D
KD
Chen
W Y
WY
Tsai
T J
TJ
D000328:Adult; D000368:Aged; D015415:Biomarkers / Q000097:blood; D004921:Erythropoietin / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005293:Ferritins / Q000097:blood*; D005500:Follow-Up Studies; D016174:Hepacivirus / Q000276:immunology; D018937:Hepatitis C Antibodies / Q000032:analysis; D019698:Hepatitis C, Chronic / Q000097:blood / Q000628:therapy*; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D006435:Renal Dialysis; D016896:Treatment Outcome
D015415:Biomarkers; D018937:Hepatitis C Antibodies; D011994:Recombinant Proteins; D004921:Erythropoietin; D005293:Ferritins